Skip to main content

Table 1 Primary criteria for study eligibility

From: Evaluation of the effects of pycnogenol (French maritime pine bark extract) supplementation on inflammatory biomarkers and nutritional and clinical status in traumatic brain injury patients in an intensive care unit: A randomized clinical trial protocol

Admission in ICU a due to TBI b
18 year ≤ age ≤ 65 year
GCS c score > 8
Stable hemodynamic and metabolic status in the first 24 to 48 h
Having enteral nutritional support
Fill out the informed consent form by the patient or first-degree relatives of the patient
  1. a Intensive care unit. b Traumatic brain injury. c Glasgow Coma Scale